-->

Ticarcillin disodium and Clavulanate potassium Dosage, Interactions, Side Effects, How to Use


Home > Drug Prescribing Database > T > Ticarcillin disodium and Clavulanate potassium


Ticarcillin disodium and Clavulanate potassium Articles

Submit an Article...

We don't currently have any articles about Ticarcillin disodium and Clavulanate potassium.

Ticarcillin disodium and Clavulanate potassium Dosage, Interactions, Side Effects, How to Use Questions

Ask a Question...

We don't currently have any questions about Ticarcillin disodium and Clavulanate potassium.

Ticarcillin disodium and Clavulanate potassium
Ticarcillin disodium and Clavulanate potassium (Timentin)
Ticarcillin disodium/Clavulanate potassium
(tie-kar- SILL-in, klav-you- LAN-ate poe- TASS-ee-um)
Pregnancy Category: B Timentin (Rx)

Classification: Antibiotic, penicillin

See Also: See also Ticarcillin disodium and Penicillins.

Content: Each vial of the Powder for Injection and the Solution contains: ticarcillin disodium, 3.1 g, and clavulanate potassium, 0.1 g.

Action/Kinetics: Contains clavulanic acid, which protects the breakdown of ticarcillin by beta-lactamase enzymes, thus ensuring appropriate blood levels of ticarcillin.

Uses: (1) Septicemia, including bacteremia, due to ß-lactamase producing strains of Klebsiella sp., Staphylococcus aureus, and Pseudomonas aeruginosa (and other Pseudomonas species). (2) Lower respiratory tract infections due to ß-lactamase producing strains of S. aureus, Haemophilus influenzae, and Klebsiella sp. (3) Bone and joint infections due to ß-lactamase producing strains of S. aureus. (4) Skin and skin structure infections due to ß-lactamase producing strains of S. aureus, Klebsiella sp., and E. coli. (5) UTIs (complicated and uncomplicated) due to ß-lactamase producing strains of E. coli, Klebsiella sp., P. aeruginosa (and other Pseudomonas species), Citrobacter sp., Enterobacter cloacae, Serratia marcescens, and S. aureus. (6) Endometritis due to ß-lactamase producing strains of B. melaninogenicus, Enterobacter sp. (including E. cloacae), E. coli, Klebsiella pneumoniae, S. aureus, and Staphylococcus epidermidis. (7) Peritonitis due to ß-lactamase producing strains of E. coli, K. pneumoniae, and Bacteroides fragilis group.

How Supplied: See Content

Dosage
?IV Infusion Systemic and UTIs.
Adults more than 60 kg: 3.1 g (containing 0.1 g clavulanic acid) q 4-6 hr for 10-14 days. Adults less than 60 kg: 200-300 mg ticarcillin/kg/day in divided doses q 4-6 hr for 10-14 days.
Gynecologic infections.
Adults more than 60 kg, moderate infections: 200 mg/kg/day in divided doses q 6 hr; severe infections: 300 mg/kg/day in divided doses q 4 hr.
In renal insufficiency.
Initially, loading dose of 3.1 g ticarcillin and 0.1 g clavulanic acid; then, dose based on C CR as follows. C CR over 60 mL/min: 3.1 g q 4 hr; C CR from 30-60 mL/min: 2 g q 4 hr; C CR from 10&endash30 mL/min: 2 g q 8 hr; C CR, less than 10 mL/min: 2 g q 12 hr; C CR, less than 10 mL/min with hepatic dysfunction: 2 g q 24 hr. Clients on peritoneal dialysis: 3.1 g q 12 hr; clients on hemodialysis: 2 g q 12 hr and 3.1 g after each dialysis.